E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/14/2010 in the Prospect News PIPE Daily.

World Heart to pocket $25.3 million via private placement of units

Brokered offering will be conducted by Lazard Capital, Wedbush PacGrow

By Devika Patel

Knoxville, Tenn., Oct. 14 - World Heart Corp. arranged a $25.3 million private placement of units on Oct. 13, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company will sell 11,850,118 units of one common share and one five-year warrant at $2.135 per unit.

The whole warrants are each exercisable at $2.31, which is equal to 115% of the closing consolidated bid price of the common stock on Oct. 13 and a 12.68% premium to the Oct. 13 closing share price of $2.05.

Lazard Capital Markets LLC and Wedbush PacGrow Life Sciences are the agents.

Salt Lake City-based World Heart is a developer of mechanical circulatory support systems.

Issuer:World Heart Corp.
Issue:Units of one common share and one warrant
Amount:$25.3 million
Units:11,850,118
Price:$2.135
Warrants:One warrant per unit
Warrant expiration:Five years
Warrant strike price:$2.31
Agent:Lazard Capital Markets LLC and Wedbush PacGrow Life Sciences
Pricing date:Oct. 13
Stock symbol:Nasdaq: WHRT
Stock price:$2.05 at close Oct. 13
Market capitalization:$29.9 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.